title: Shotgun proteomic analysis of S-thiolation sites of guinea pig lens nuclear crystallins following oxidative stress in vivo.
abstract: OBJECTIVE
  To compare levels of S-glutathiolation and S-cysteinylation occurring at more than 60 cysteine residues of 12 different guinea pig lens water-soluble nuclear crystallins following treatment of the animals with hyperbaric oxygen (HBO).
  
  
  METHODS
  Guinea pigs (initially 18 months old) were treated 30X (3X per week for 10 weeks) with HBO (2.5 atm 100% O(2) for 2.5 h) as a model to study the formation of nuclear cataract. This treatment produces a moderate increase in lens nuclear light scatter (compared to denser scatter occurring after 80 HBO treatments), with five- to sixfold increases in levels of protein-bound glutathione (PSSG) and protein-bound cysteine (PSSC). Trypsin digests of lens nuclear water-soluble proteins were analyzed with two-dimensional liquid chromatography and mass spectrometry to identify specific cysteine residues binding either glutathione or cysteine. Lens nuclei of age-matched untreated animals were used as controls.
  
  
  RESULTS
  All major crystallins, except αB, were modified to some extent by either S-glutathiolation or S-cysteinylation. Overall, 72% of the cysteine residues of guinea pig lens nuclear crystallins were shown to be capable of binding glutathione, cysteine, or both molecules. The crystallin with the highest level of modification was βA1/A3 (six of eight -SH groups), and that with the lowest (two of five -SH groups) was βA2. O(2)-induced increases in PSSG levels were 2.8, 2.4, and 4.1 times control for γA-, γB-, and γC-crystallins, respectively. Comparable increases in PSSC levels for the three γ-crystallins were 2.3, 2.7, and 2.4 times control, respectively. βB2-crystallin showed the highest amount of O(2)-induced PSSG formation of any of the crystallins, as well as a substantial level of control PSSG, and nearly all of this was due to a single residue, C67, a site also present in human βB2-crystallin. Overall, 32 of the 44 modified cysteine residues were homologous with the human.
  
  
  CONCLUSIONS
  This large-scale study successfully identified lens crystallin cysteine residues that bound glutathione and/or cysteine under normal or oxidative stress conditions. The high percentage of protein -SH groups that are modified by S-thiolation in the guinea pig lens nucleus demonstrates the substantial protein sulfhydryl redox buffer capability present in the center of the lens. The results suggest that PSSG and PSSC formation may act to delay O(2)-induced insolubilization of γA-, γB-, and γC-crystallins, and β-crystallins, but with a greater effect on the γ-crystallins at an early stage of oxidative stress. The study has shown that technological approaches are now available to investigate in considerable detail the role of specific lens -SH groups in nuclear cataractogenesis.
authors: Eye Research Institute, Oakland University, Rochester, MI 48309, USA. giblin@oakland.edu
authors: Frank J
authors: FJ
authors: Giblin
authors: Larry L
authors: LL
authors: David
authors: Phillip A
authors: PA
authors: Wilmarth
authors: Victor R
authors: VR
authors: Leverenz
authors: M Francis
authors: MF
authors: Simpanya
mesh_terms: D000818:Animals; D001665:Binding Sites; D002386:Cataract / Q000209:etiology / Q000378:metabolism; D003459:Crystallins / Q000737:chemistry* / Q000378:metabolism*; D003545:Cysteine / Q000737:chemistry; D004195:Disease Models, Animal; D005978:Glutathione / Q000737:chemistry; D006168:Guinea Pigs; D018496:Hyperoxia / Q000378:metabolism; D007907:Lens Nucleus, Crystalline / Q000378:metabolism*; D018384:Oxidative Stress; D011499:Protein Processing, Post-Translational; D040901:Proteomics / Q000379:methods*; D012995:Solubility; D013438:Sulfhydryl Compounds / Q000737:chemistry; D053719:Tandem Mass Spectrometry
chemical_list: D003459:Crystallins; D013438:Sulfhydryl Compounds; D005978:Glutathione; D003545:Cysteine
references: Protein Sci. 2005 Jan;14(1):45-54
references: 15576560
references: Mol Syst Biol. 2011 Oct 11;7:539
references: 21988835
references: Exp Eye Res. 1965 Dec;4(4):327-39
references: 4956219
references: IUBMB Life. 2005 Mar;57(3):189-92
references: 16036581
references: Exp Eye Res. 2009 Feb;88(2):286-92
references: 18835558
references: Proc Natl Acad Sci U S A. 1980 Mar;77(3):1274-7
references: 6929483
references: Nat Methods. 2007 Mar;4(3):207-14
references: 17327847
references: J Biol Chem. 1997 Nov 14;272(46):29099-103
references: 9360985
references: Exp Eye Res. 1992 Dec;55(6):889-96
references: 1486943
references: Anal Chem. 2002 Oct 15;74(20):5383-92
references: 12403597
references: Biochim Biophys Acta. 1977 May 27;492(1):43-52
references: 861252
references: Exp Eye Res. 2005 May;80(5):709-25
references: 15862178
references: Protein Sci. 2005 May;14(5):1282-92
references: 15840832
references: J Ocul Pharmacol Ther. 2000 Apr;16(2):137-48
references: 10803424
references: Ophthalmic Res. 2010;44(3):155-65
references: 20829639
references: Dev Ophthalmol. 2002;35:60-9
references: 12061279
references: Exp Eye Res. 1999 May;68(5):547-52
references: 10328968
references: Biochim Biophys Acta. 2008 Dec;1784(12):1959-64
references: 18761110
references: Invest Ophthalmol Vis Sci. 1998 Aug;39(9):1609-19
references: 9699550
references: FASEB J. 1991 Feb;5(2):223-5
references: 2004667
references: Exp Eye Res. 2001 Mar;72(3):279-88
references: 11180977
references: Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3061-73
references: 10967065
references: Exp Eye Res. 2000 Oct;71(4):371-83
references: 10995558
references: J Mol Biol. 1994 Mar 4;236(4):1250-8
references: 8120900
references: Free Radic Biol Med. 2007 Sep 15;43(6):883-98
references: 17697933
references: Exp Eye Res. 2004 Dec;79(6):823-31
references: 15642319
references: Biochem J. 2004 May 1;379(Pt 3):595-600
references: 14763903
references: J Proteome Res. 2006 Oct;5(10):2554-66
references: 17022627
references: Mol Vis. 2008;14:2413-27
references: 19104676
references: Biochim Biophys Acta. 1999 Jul 13;1432(2):286-92
references: 10407150
references: Br J Ophthalmol. 2004 Dec;88(12):1512-7
references: 15548802
references: J Mol Biol. 1999 Mar 5;286(4):989-94
references: 10047476
references: Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):348-66
references: 15706083
references: J Mol Biol. 1983 Oct 15;170(1):175-202
references: 6631960
references: Biol Pharm Bull. 1993 Sep;16(9):870-5
references: 8268853
references: Exp Eye Res. 1989 Feb;48(2):225-35
references: 2924810
references: Antioxid Redox Signal. 2008 Mar;10(3):445-73
references: 18092936
references: J Biol Chem. 1994 Apr 29;269(17):12494-502
references: 8175657
references: Am J Ophthalmol. 1951 May;34(5 2):104-13
references: 14829519
references: Exp Eye Res. 1995 Mar;60(3):219-35
references: 7789403
references: Invest Ophthalmol Vis Sci. 2004 Jan;45(1):77-85
references: 14691157
references: Exp Eye Res. 2000 Aug;71(2):195-207
references: 10930324
references: J Ocul Biol Dis Infor. 2009 Dec 12;2(4):223-234
references: 20157357
references: Arch Biochem Biophys. 1991 Jan;284(1):181-5
references: 1989495
references: J Biol Chem. 1999 Feb 19;274(8):4735-42
references: 9988710
references: J Biol Chem. 1992 Jan 5;267(1):96-102
references: 1370456
references: Protein Sci. 2003 Nov;12(11):2606-12
references: 14573871
references: Mol Vis. 2006 Jun 21;12:704-11
references: 16807530
references: Biochem Biophys Res Commun. 1990 Mar 30;167(3):1221-8
references: 2322267
references: Br J Ophthalmol. 1984 Feb;68(2):113-7
references: 6691953
references: Nat Biotechnol. 1999 Jul;17(7):676-82
references: 10404161
references: Exp Eye Res. 1992 Jul;55(1):127-33
references: 1397121
references: Protein Sci. 2007 Apr;16(4):615-25
references: 17327390
references: Biochemistry. 2011 Oct 11;50(40):8628-35
references: 21877723
references: Arch Biochem Biophys. 1995 May 10;319(1):1-9
references: 7771771
references: Exp Eye Res. 1998 Sep;67(3):301-12
references: 9778411
references: Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4641-51
references: 16303961
references: J Biol Chem. 2000 Apr 21;275(16):11585-90
references: 10766773
references: Ophthalmology. 2008 May;115(5):808-814.e1
references: 17900695
references: Am J Ophthalmol. 2005 Feb;139(2):302-10
references: 15733992
references: Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):422-7
references: 19122143
references: J Mol Biol. 1991 Dec 20;222(4):1067-83
references: 1762146
references: Exp Eye Res. 1999 Apr;68(4):493-504
references: 10192807
references: Exp Eye Res. 1997 Apr;64(4):609-14
references: 9227279
references: Biochem J. 1985 Aug 15;230(1):143-50
references: 4052032
references: Nature. 1981 Feb 26;289(5800):771-7
references: 7464942
references: J Protein Chem. 1995 Apr;14(3):179-88
references: 7576086
references: Exp Eye Res. 1982 Jan;34(1):23-37
references: 7056309
references: Arch Biochem Biophys. 1996 Apr 1;328(1):173-83
references: 8638928
references: Curr Eye Res. 1997 Jul;16(7):719-24
references: 9222091
references: Philos Trans R Soc Lond B Biol Sci. 2011 Apr 27;366(1568):1293-300
references: 21402587